Professor Ivan HUNG is currently Chair Professor of Infectious Diseases, Ru Chien and Helen Lieh Endowed Professor in Health Sciences Pedagogy, Associate Dean (Partnership & Engagement), Head of the Division of Infectious Diseases, Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong. Professor Hung is a dual specialist in Infectious Disease and Gastroenterology & Hepatology. He is the Fellow of Royal Colleges of Physicians of London and Edinburgh, and fellow of the Infectious Disease Society of America. He is currently Associate Editor of the two medical journals: Vaccine; Diagnostics. Professor Hung has published more than 370 international peer reviewed original articles, including research articles in the Lancet, Nature, the Lancet Infectious Diseases and the Clinical Infectious Diseases. His research interest includes influenza, SARS-CoV-2 and other respiratory virus antiviral treatment and vaccinology. He has pioneered the use of the triple combination of interferon beta-1b, lopinavir/ ritonavir and ribavirin in the treatment of hospitalized COVID-19 patients, resulting in significantly faster recovery and viral load suppression. He and his team also pioneered the application of topical imiquimod before intradermal influenza vaccination, which results in protection against heterologous non-vaccine and antigenically drifted viruses. He is ranked as HKU Scholars in the world top 1% in 2013, 2018-2023 (H-index 70), most highly cited researcher in 2023 by the Clarivate and top 2% Scientists Worldwide 2023 in Specialty Areas by Stanford University.